University at Buffalo experiments from a day care center have revealed that two common bacteria persist on various surfaces for extended periods of time.


Based on their published scientific articles, two University at Buffalo physician-scientists have been recognized as leading investigators in their medical specialties by the global health care information website Expertscape.

A University at Buffalo study has revealed how Streptococcus pneumoniae—bacteria that harmlessly colonize the mucous linings of human throats and noses—become virulent when they travel to the middle ears, lungs or bloodstream.

Researchers in the Department of Microbiology and Immunology have developed a new way to stimulate an immune response to gonorrhea.


More than 100 student scientists from across the country showcased their original research during this summer’s University at Buffalo Biomedical Research Day.


UB researchers have found that a protein complex in human breast milk can force drug-resistant bacteria to respond to antibiotics again.


The UB Clinical and Translational Science Institute showcased award-winning studies and novel technologies developed jointly by UB researchers and collaborators.


Researchers have discovered a new vaccine target for tuberculosis using a UB-patented adjuvant that boosts the potency of mucosal vaccines.


Innovations developed at least in part by faculty at UB’s School of Medicine and Biomedical Sciences accounted for nearly 40 percent of the provisional patent applications filed by the university in 2012.


UB researchers will use a $1.6 million grant from the National Institutes of Health to develop the first vaccine against an understudied bacterium that causes at least 10 percent of middle ear infections in children.

UB microbiologists studying bacterial colonization in mice have discovered how the bacteria associated with pneumonia, middle ear infections and other illnesses acquire and spread resistance.
Biomedical researchers have discovered a novel, previously unrecognized set of genes essential for the growth of potentially lethal drug-resistant bacteria.

Thomas Russo and colleagues are studying a hypervirulent strain of a common bacterium that has the potential to become a superbug.


Sanjay Sethi is researching better drugs for COPD; Thomas Russo is exploring new targets for a multidrug-resistant pathogen.


Timothy F. Murphy, MD, has been named director of the UB Clinical and Translational Science Institute, scheduled to open this May on the Buffalo Niagara Medical Campus.


Timothy Murphy, MD, and Thomas Russo, MD, professors in the Department of Medicine, are contributors to the newly published Harrison’s Principles of Internal Medicine, 18th Edition.


The inaugural Combined Summer Undergraduate Research Day featured the research of talented students who came to UB and HWI from around the country to participate in summer programs.


Timothy F. Murphy, MD, senior associate dean for clinical and translational research, has been named a SUNY Distinguished Professor.